In one study, 12-week treatment with insulin glargine vs liraglutide (mean dose = 1.3 mg/day) showed similar glycemic control and decrease of hepatic fat burden, although a reduction in BMI was only observed in the liraglutide-treated patients (68)
Call (405) 510-0077 or contact us now for a free, no-obligation consultation
The FDA should also flag what the Partnership calls rogue foreign manufacturers so that future shipments from these sources are more easily detected and, if needed, blocked
Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes
Most of us are able to make or consume the carnitine we need, although those with kidney disease, certain genetic disorders or who follow restrictive diets may be at risk of lower levels
doi:10.1111/add.15454 Jerzyski T, Stimson GV, Shapiro H, Krl G